Source comparison
The Receptor Systems: Central vs Peripheral Activation
PT-141's mechanism begins at melanocortin receptors. Specifically MC3R and MC4R subtypes located in hypothalamic nuclei. When bremelanotide binds these G-protein coupled receptors, it triggers intracellular signalling cascades that elevate cyclic AMP (cAMP) le
This comparison does not assign a generated winner or score.
- PT-141's mechanism begins at melanocortin receptors. Specifically MC3R and MC4R subtypes located in hypothalamic nuclei. When bremelanotide binds these G-protein coupled receptors, it triggers intracellular signalling cascades that elevate cyclic AMP (cAMP) levels, activating protein kinase A and downstream transcription factors that upregulate dopamine and oxytocin release. This neurochemical cascade produces central arousal. The subjective experience of desire and the autonomic preparation for sexual activity. Independent of genital stimulation. Studies using MC4R knockout mice demonstrated complete abolition of bremelanotide's pro-arousal effects, confirming receptor specificity.
- Viagra's mechanism operates exclusively in peripheral vascular tissue. During sexual arousal, parasympathetic nerve terminals release nitric oxide (NO) into corpus cavernosum smooth muscle. NO activates soluble guanylate cyclase, which converts GTP to cyclic GMP. The molecule that triggers smooth muscle relaxation, arterial dilation, and blood engorgement. PDE5 is the enzyme that degrades cyclic GMP back to GMP, terminating the erection. Sildenafil competitively inhibits PDE5 with an IC50 of 3.5 nM, blocking cyclic GMP breakdown and extending the duration and rigidity of the vascular response. Without initial NO release from arousal, Viagra produces no effect. It amplifies a signal, it doesn't create one.
- The practical research implication: PT-141 studies test central arousal pathways (hypothalamic signalling, dopamine receptor function, neurotransmitter dynamics). Viagra studies test peripheral vascular function (endothelial NO synthesis, smooth muscle contractility, PDE isoform selectivity). They're not interchangeable experimental tools.